Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Promis Neurosciences (PMN) had Stock-Based Compensation of $0.19M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-8.24M |
|
-- |
|
-- |
|
$8.64M |
|
$-8.64M |
|
$0.40M |
|
$-8.24M |
|
$-8.24M |
|
$-8.24M |
|
$-8.24M |
|
$-8.24M |
|
$-8.24M |
|
$-8.64M |
|
$-8.64M |
|
6.53M |
|
6.53M |
|
$-1.26 |
|
$-1.26 |
|
| Balance Sheet Financials | |
$65.61M |
|
-- |
|
$1.80M |
|
$67.41M |
|
$6.61M |
|
-- |
|
$0.08M |
|
$6.69M |
|
$60.72M |
|
$60.72M |
|
$60.72M |
|
8.97M |
|
| Cash Flow Statement Financials | |
$-12.38M |
|
-- |
|
$70.08M |
|
$6.12M |
|
$63.81M |
|
$57.70M |
|
|
Stock-Based Compensation |
$0.19M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.58% |
|
-13.58% |
|
-12.23% |
|
-13.58% |
|
$6.77 |
|
$-1.90 |
|
$-1.90 |
|